Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries
- 1 February 2006
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 55 (2) , 215-221
- https://doi.org/10.1099/jmm.0.46268-0
Abstract
The pneumococcal surface protein PspA, a cell-wall-associated surface protein, is a promising component for pneumococcal vaccines. In this study, the distribution of the PspA family was determined in a panel of invasive and clinically important pneumococcal isolates from adults over 50 years of age, collected between 1995 and 2002. One thousand eight hundred and forty-seven recent isolates from invasive pneumococcal disease were obtained from seven Western countries, together with clinical data. An ELISA-based serological method was standardized in order to determine the PspA family and clade distribution. Molecular tests were used when isolates were non-typable by ELISA (PspA family typing by PCR). Only 42 (2·3 %) isolates were non-typable by ELISA and PspA family typing by PCR was performed. Finally, 3 isolates were considered as non-pneumococcal and 1844 were classified as follows: 749 (40·6 %) were PspA family 1, 1078 (58·5 %) were PspA family 2, 13 (0·7 %) were PspA family 1 and 2 and 4 (0·2 %) remained non-typable. The cross-reactivity of antibodies to PspAs of different clades was confirmed. In conclusion, inclusion of PspA family 1 and family 2 in future pneumococcal vaccines would ensure broad coverage of pneumococcal strains infecting people over 50 years of age.Keywords
This publication has 22 references indexed in Scilit:
- Relationship between Surface Accessibility for PpmA, PsaA, and PspA and Antibody-Mediated Immunity to Systemic Infection by Streptococcus pneumoniaeInfection and Immunity, 2005
- Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal diseaseVaccine, 2004
- Typing of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolated during epidemiological surveillance in Brazil: towards novel pneumococcal protein vaccinesVaccine, 2004
- Pneumococcal vaccines: an update on current strategiesVaccine, 2004
- Effectiveness of Pneumococcal Polysaccharide Vaccine in Older AdultsNew England Journal of Medicine, 2003
- Clonal Relationships between Invasive and CarriageStreptococcus pneumoniaeand Serotype‐ and Clone‐Specific Differences in Invasive Disease PotentialThe Journal of Infectious Diseases, 2003
- Immunization of Humans with Recombinant Pneumococcal Surface Protein A (rPspA) Elicits Antibodies That Passively Protect Mice from Fatal Infection withStreptococcus pneumoniaeBearing Heterologous PspAThe Journal of Infectious Diseases, 2000
- Diversity of PspA: Mosaic Genes and Evidence for Past Recombination in Streptococcus pneumoniaeInfection and Immunity, 2000
- Immunogenicity of pneumococcal conjugate vaccinesThe Pediatric Infectious Disease Journal, 2000
- Intranasal Immunization of Mice with a Mixture of the Pneumococcal Proteins PsaA and PspA Is Highly Protective against Nasopharyngeal Carriage ofStreptococcus pneumoniaeInfection and Immunity, 2000